Tolterodine

CHEMBL1382 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

325.5 g/mol

LogP

5.6

Phase

4

This medication is used to treat overactive bladder, a condition characterized by frequent, urgent, and sometimes uncontrollable urination. It works by relaxing the bladder muscle by blocking muscarinic receptors, reducing urinary urgency and frequency. Common side effects include dry mouth and constipation.

分子量

325.5000 g/mol

LogP

5.60

TPSA

23.50 Å²

リピンスキーの五則

適合

治療領域

Benign Prostatic Hyperplasia Pain Management Chronic Pain

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1ccc(O)c([C@H](CCN(C(C)C)C(C)C)c2ccccc2)c1

InChI

InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1

Molecular Formula

C22H31NO

HBD / HBA

1 / 2

回転可能結合数

7

重原子数

24

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

This medication is used to treat overactive bladder, a condition characterized by frequent, urgent, and sometimes uncontrollable urination. It works by relaxing the bladder muscle by blocking muscarinic receptors, reducing urinary urgency and frequency. Common side effects include dry mouth and constipation.

Yes, Tolterodine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1382. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 443879. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Tolterodine PillFYIで

構造

クイックデータ

分子式: C22H31NO
同義語: 4

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.